secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001193125-25-269992
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro to acquire IRRAS for $5M cash + 1.325M shares; combined 2026 rev $54-60M
--------------------------------------------------------------------------------

- Total consideration: $5M cash plus 1.325M ClearPoint shares; earnout of 25% of net IRRA flow sales above thresholds.
- IRRAS's IRRA flow catheter addresses ~400K US procedures/yr, targeting a $0.5B global intracranial bleeding market.
- IRRAS has >50 active customers and 83% growth in first 9 months of 2025 to ~$9M revenue run-rate.
- Combined entity expected to have 40+ additional commercial professionals; 2026 revenue guidance $54M-$60M.
- Transaction approved by both boards; closing conditions include IRRAS stockholder approval and Nasdaq Stockholm delisting by Dec 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000119312525269992/0001193125-25-269992-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000119312525269992/clpt-20251106.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-269992

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer